Why is Krebs Biochem falling/rising?

As of 24-Sep, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at 76.95, reflecting a decrease of 4.05, or 5.0%. The stock has underperformed significantly today, with a performance that is 99.55% lower than its sector. Additionally, the stock has not traded on one day out of the last 20, indicating erratic trading behavior. It is also trading below all its moving averages, which suggests a bearish trend. The company has reported negative results for the last three consecutive quarters, with net sales and profit after tax both declining by 53.42%. This poor performance, coupled with a negative book value and a high debt-to-equity ratio, contributes to a weak long-term fundamental strength, leading to a strong sell recommendation.
In the broader market context, Krebs Biochem's short-term performance over the past week shows a decline of 5.00%, while the benchmark Sensex has only fallen by 1.18%. Over the past year, Krebs Biochem has generated a return of -10.41%, significantly underperforming the benchmark, which has declined by only 3.77%. This consistent underperformance against the benchmark over the last three years, alongside a substantial drop in investor participation and liquidity, further exacerbates the stock's negative outlook. The overall market conditions and the company's financial struggles indicate that the stock is facing significant challenges, leading to its current downward trajectory.